Isometric tension responses of isolated porcine coronary artery rings were studied in the presence of concentrations of propranolol higher than those necessary to block effects mediated by β-adrenergic receptors. Propranolol (50-300 μM) inhibited contractions induced by 30mM KCl and by histamine, norepinephrine, and acetylcholine in a concen tration-dependent, noncompetitive fashion. The (+) propranolol isomer and the racemic mixture were equipotent inhibitors of contraction. Propranolol inhibition was partly reversed by increased extracellular Ca++. These effects of propranolol thus appeared to be independent of β-blockade and could be relevant to some of the drug's observed but still unexplained in vivo actions.
Frishman WH: Beta-adrenergic blockers. Med Clin North Am72:37-44, 1988.
3.
Nies AS, Woosley RL: The non-beta-adrenergic blocking actions of propranolol. In: Beta-adrenergic Blockade; a New Era in Cardiovascular Medicine, ed. by Braunwald E.New York : Excerpta Medica/Elsevier1978, pp 113-130.
4.
Duff HJ, Mitchell LB, Wyse DG: Antiarrhythmic efficacy of propranolol: A comparison of low and high serum concentrations. J Am Coll Cardiol8:959, 1986.
5.
Shand DG: Propranolol. N Engl J Med293:280-284, 1975.
6.
Godun DV, Ng TW, Tuchek JM: Studies on the interaction of propranolol with erythrocyte membranes . Biochem Biophys Acta436:757-773, 1976.
7.
Bohr DF: Adrenergic receptors in coronary arteries. Ann NY Acad Sci139:799-807, 1967.
8.
Parratt JR: Effects of adrenergic activators and inhibitors on the coronary circulation . In: Adrenergic Activators and Inhibitors (Part I), ed. by Szekeres L.Berlin: Springer-Verlag1980, pp 735-822.
9.
Maseri A., Chierchia S.: Coronary artery spasm: Demonstration, definition, diagnosis, and consequences . Prog Cadiovasc Dis25:169-192, 1982.
10.
Johansson B. : The B-adrenoceptors in the smooth muscle of pig coronary arteries. Eur J Pharmacol24:218-224, 1973.
11.
Bevan J., Su C.: Nerve-muscle preparations of vascular smooth muscle. In: Smooth Muscle, ed. by Daniel EE, Paton DM (Methods in Pharmacology, vol. 3, ed. by Schwartz A.).New York: Plenum Press1975, pp. 439-446.
12.
Furchgott RF : The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Catecholamines , ed. by Blaschko H, Muscholl E.Berlin : Springer-Verlag1972, pp 283-335.
13.
Skanashi M. , Nishi K.: Relaxation of isolated dog coronary artery induced by propranolol. Eur J Pharmacol70:83-85, 1981.
14.
Rajfer SI, Kohli JD, Goldberg LI: Contractile actions of racemic and d-propranolol on isolated canine mesenteric and coronary arteries. J Pharmacol Exp Ther220:127-132, 1982.
15.
Howe R., Shanks RG: Optical isomers of propranolol. Nature210:1336-1338, 1966.
16.
Walle T., Webb JG, Bagwell EE, et al: Stereoselective delivery and actions of beta receptor antagonists . Biochem Pharmacol37:115-124, 1988.
17.
Hester RK, Weiss GB: Comparison of degree of dependence of canine renal arteries and veins on high and low affinity calcium for responses to norepinephrine and potassium . J Pharmacol Exp Ther216:239-246, 1981.
18.
Weksler BB, Gillick M., Pink J.: Effect of propranolol on platelet function. Blood49:185-196, 1977.
19.
Akaike N., Ito H., Nishi K., et al: Further analysis of the inhibitory effects of propranolol and local anesthetics on the calcium current in Helix neurones. Br J Pharmacol76:37-43, 1982.
20.
Lichtman MA , Cohen J., Murphy MS, et al: Effect of propranolol on oxygen binding to hemoglobin in vitro and in vivo. Circulation49:881-886, 1974.
21.
Pruett JK, Walle T., Walle UK: Propranolol effects on membrane repolarization time in isolated canine Purkinje fibers: Threshold tissue content and the influence of exposure time . J Pharmacol Exp Ther215:539-543, 1980.
22.
Man in't Veld AJ, Van den Meiracker AH, Schalekamp MA: Do beta-blockers really increase peripheral vascular resistance? Review of the literature and new observations under basal conditions. Am J Hypertension1:91-96, 1988.
23.
Frishman WH : Pindolol: A new beta-adrenoreceptor antagonist with partial agonist activity. N Engl J Med308:940-944, 1983.
24.
Campbell WB, Johnson AR, Callahan KS, et al: Antiplatelet activity of beta-adrenergic antagonists: Inhibition of thromboxane synthesis and platelet aggregation in patients receiving long-term propranolol treatment. Lancetii:1382-1384, 1981.
25.
Hollifield JW , Sherman K., Vander Zwagg R, et al: Proposed mechanisms of propranolol's antihypertensive effect. N Engl J Med295:68-73, 1976.
26.
Woosley RL, Kornhauser D., Smith R., et al: Suppression of chronic ventricular arrhythmias with propranolol . Circulation60:819-827, 1979.
27.
Robertson RM , Wood Ajj, Vaughn WK, et al: Exacerbation of vasotonic angina pectoris by propranolol. Circulation65:281-285, 1982.
28.
Brochier M., Fauchier JP, Charbonnier B., et al: Treatment of Prinzmetal's angina by beta-blocking agents: In: Coronary Arterial Spasm, ed. by Bertrand M.Paris: Laboratories Dausse, 1979, pp 445-454.
29.
Guazzi M., Fiorentini C., Polese A., et al: Treatment of spontaneous angina pectoris with beta-blocking agents: A clinical, electrocardiographic, and hemodynamic appraisal. Br Heart J37:1235-1245, 1975 .
